Showing results (1-10 of 238) with videos related to
Sort By:
Pageof 24
Expert Review of Molecular Diagnostics|November 5, 2016
Towards diagnostic application of non-coding RNAs in neuroblastomaKristina Althoff, Johannes H Schulte, Alexander SchrammClinical & Experimental Ophthalmology|September 21, 2016
Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell linesMelanie Schwermer, Sabine Dreesmann, Angelika Eggert, et al.Journal for Immunotherapy of Cancer|May 21, 2021
Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastomaJohanna A Seier, Julia Reinhardt, Kritika Saraf, et al.Oncotarget|April 22, 2017
RITA displays anti-tumor activity in medulloblastomas independent of TP53 statusAline Gottlieb, Kristina Althoff, Laura Grunewald, et al.Oncotarget|November 16, 2013
BET bromodomain protein inhibition is a therapeutic option for medulloblastomaAnton Henssen, Theresa Thor, Andrea Odersky, et al.Laryngo- Rhino- Otologie|August 30, 2022
[Principals of Osteosynthesis in the Facial Skeleton]Frank Wilde, Alexander SchrammFacial Plastic Surgery : FPS|November 15, 2014
Intraoperative imaging in orbital and midface reconstructionFrank Wilde, Alexander SchrammHuman Vaccines & Immunotherapeutics|April 21, 2016
MYCN-targeting vaccines and immunotherapeuticsAlexander Schramm, Holger LodeInternational Journal of Cancer|February 13, 2013
MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1AKristina Althoff, Anneleen Beckers, Andrea Odersky, et al.Cancer Letters|January 7, 2019
Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastomaYoujia Han, Sven Lindner, Yi Bei, et al.Pageof 24